* IVAGEN *
2002 - Méditerranée
Bernis
(near Nîmes)
www.ivagen.com Discovery, Diagnostics
Key words: Immuno-hematology, Medical devices, HIV, H5N1
Mission: to develop, manufacture and distribute reagents to assist third parties in human, veterinary and plant diagnosis, and to discover proprietary immuno-diagnostics
Clients: Research labs
contact@ivagen.com
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Personal venture |
Managing Dir.: Skorski (Gilbert) [born 1955]
Sc.Dir.: Da Costa (Jean-Manuel)
Fin.Dir.:
BusDev:
Financers: Matignon I.G., OTC Asset Management (33%)
Communication: website under construction, since long | Turnover (M€) : 1.05 (2006)
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : Virus
Position : Trade
Company confirm : none |
History | DATE | MILESTONE | TYPE | TIME | | 2007 .04 | Round-financing : undisclosed M€, by Matignon I.G., OTC Asset Management (after receivership in 2004) | RFIN | [5 years] |
| 2002 .02 | Company founded by Jean-Claude Aziza (unexpectedly deceased in 2006), Gilbert Skorski | ORGF | [0 year] | Actualisation / Updating: 31-Oct-2008 |
|
